Helena Bioinformatics — Undertone

Every association
has an undertone.

Undertone turns genetic associations into testable biological hypotheses. It combines GWAS, fine-mapping, regulatory, expression, and functional evidence to show which variant likely acts, in which cell type, on which gene, through which mechanism.

Mechanism, predicted
Association, observed

Drag to see what's underneath

A GWAS hit tells you a locus moved. It doesn't say which variant did it, in which cell, on which gene, or by what mechanism. Most tools stop at the association. Undertone keeps going, and shows its work at every step.
The problem with a single confidence score

Real handoff · interface-shaped

Show the data we have. Show the gaps we do not.

The current TCF7L2 handoff is rendered without filling in missing science. Two source records become four allele-specific identities, while every absent artifact stays explicit.

Submission preview

TCF7L2 credible-set handoff

Validation incomplete
!
Source discrepancy requires clarification

The email named only C>T and G>T. The supplied VCF contains ALT G,T and A,T. Undertone preserves the file and exposes all four identities rather than guessing which alleles were intended.

Allele-specific variantCredible setPosteriorEvidence
Why no ranking?

Credible-set membership is present, but the handoff has no fine-mapping method, posterior values, parameters, or source. Undertone must not manufacture a rank.

Submission package completeness

Present fields are not equivalent to a validated dossier.

PresentVCF 4.2 text attachment
PresentGRCh38 declaration
PresentCredible-set flag
MissingManifest and checksums
MissingFine-mapping method and PP
MissingATAC peaks and provenance
MissingFootprints and QC
MissingTarget-gene assertions
ReceivedValidation blockedAnnotatingReady for reviewReviewed

Illustrative enriched dossier

Enter the relationships, not just the result.

Select a candidate variant. Follow its regulatory path. Open any node to see what supports it, where it came from, and what remains uncertain.

Demonstration dataThis second view shows the target interaction once statistical, regulatory, expression, and target-gene evidence exists. Values below are illustrative and are not results from the current TCF7L2 handoff.
TCF7L2 locus Type 2 diabetes · GRCh38
3 candidates · 7 evidence layers
GWAS
Credible set
Islet ATAC
Genes
TCF7L2
ACSL5

Mechanism map

rs4506565

chr10:112,996,282 C>T
Leading candidate
Current hypothesis

The risk allele may reduce islet enhancer activity and alter TCF7L2 regulation in pancreatic beta cells.

!

Uncertainty stays visible

The proposed mechanism lacks direct perturbation evidence.

Undertone carries the gap forward and identifies the experiment that could resolve it instead of hiding it behind a score.

The evidence model

From locus to hypothesis, one layer at a time.

Each layer narrows the field. What's known stays separate from what's inferred, so the hypothesis at the bottom is only as strong as the evidence stacked above it.

Observed
Predicted
Disputed
Missing validation
GWAS signal Observed

A locus crosses genome-wide significance in one or more cohorts.

Fine-mapping Observed

Statistical fine-mapping narrows the signal to a credible set of candidate variants.

Regulatory context Predicted

Chromatin state and transcription factor footprints flag which candidate sits in active regulatory sequence.

Expression evidence Observed

eQTL and allele-specific expression data link the variant to a candidate target gene.

Functional evidence Often missing

Reporter assays, MPRA, or CRISPR perturbation would confirm the variant changes activity. Most loci don't have this yet, and Undertone says so plainly.

Mechanism hypothesis Assembled

One stated hypothesis: this variant, in this cell type, acts on this gene, through this mechanism, traceable back to every layer above.

Example dossier

What a variant's file actually looks like.

A working example. Each row keeps its evidence type visible, so nothing observed gets mistaken for something predicted.

rs4506565 · TCF7L2 locus

Type 2 diabetes, pancreatic islet

GWAS association
Observed
Genome-wide significant across four independent cohorts.
Fine-mapping
Observed
Credible set of three variants, this one carries the highest posterior probability.
Islet eQTL
Observed
Associated with reduced TCF7L2 expression specifically in islet tissue.
Enhancer looping
Predicted
Chromatin contact model predicts a link to the TCF7L2 promoter. Not directly measured in islet cells.
Functional validation
Missing
No reporter assay or CRISPR perturbation data yet for this variant.
Stated hypothesis Reduced enhancer activity lowers TCF7L2 expression in pancreatic islet cells. Confirmed through expression evidence. Not yet confirmed through direct functional testing.

Method

How a locus becomes a hypothesis.

01

Ingest

Pull GWAS, fine-mapping, regulatory, and expression evidence for a locus from public and licensed sources.

02

Separate

Split observed data from computational prediction, and flag where sources disagree.

03

Map

Trace each candidate variant to its likely target gene and cell context.

04

Hypothesize

Assemble one testable mechanism statement, with every claim traceable to its evidence.

05

Flag gaps

Mark exactly what still needs experimental validation, instead of hiding it behind a score.

Stop trusting the surface color.

Undertone is in early access for research groups working on GWAS follow-up and variant-to-function studies.

Request access